ArticleDrug design, development and therapy2025

RET Inhibitor SPP86 Is a Potential Candidate for the Clinical Treatment of Cutaneous Melanoma [Letter].

Yingjian Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.